CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Jintanat Ananworanich(HIV Netherlands Australia Thailand Research Collaboration), Angèle Gayet‐Ageron(University Hospital of Geneva), Michelle Le Braz(University Hospital of Geneva), Wisit Prasithsirikul, Ploenchan Chetchotisakd(Khon Kaen University), Sasisopin Kiertiburanakul(Ramathibodi Hospital), Warangkana Munsakul(Bangkok Metropolitan Administration), Phitsanu Raksakulkarn(SanPaTong Hospital), Somboon Tansuphasawasdikul(Buddhachinaraj Hospital), Sunee Sirivichayakul(Chulalongkorn University), Matthias Cavassini, Urs Karrer(University Hospital of Zurich), Daniel Genné(International Museum of Horology), Reto Nüesch(University Hospital of Basel), Pietro Vernazza(Kantonsspital St. Gallen), Enos Bernasconi(Ospedale regionale di Lugano), Dominic Leduc, Claudette Satchell(National Centre for Clinical Research on Emerging Drugs), Sabine Yerly(University Hospital of Geneva), Luc Perrin(University Hospital of Geneva), Andrew Hill(University of Liverpool), Thomas Perneger(University Hospital of Geneva), Praphan Phanuphak(HIV Netherlands Australia Thailand Research Collaboration), Hansjakob Furrer(University Hospital of Bern), David A. Cooper(National Centre for Clinical Research on Emerging Drugs), Kiat Ruxrungtham(HIV Netherlands Australia Thailand Research Collaboration), Bernard Hirschel(University Hospital of Geneva)
Cited by 240Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis